AbbVie

$110.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.40 (-0.36%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AbbVie and other stocks, options, and ETFs commission-free!

About ABBV

ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. The listed name for ABBV is ABBVIE INC.

CEO

Richard A. Gonzalez

Employees

30,000

Headquarters

North Chicago, Illinois

Founded

2011

Market Cap

198.11B

Price-Earnings Ratio

23.44

Dividend Yield

4.26

Average Volume

6.99M

High Today

$111.60

Low Today

$109.48

Open Price

$110.57

Volume

5.18M

52 Week High

$113.41

52 Week Low

$62.55

Collections

Analyst Ratings

73%

of 22 ratings

Buy

73%

Hold

27%

Sell

ABBV Earnings

$0.00

$0.94

$1.89

$2.83

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Feb 3, Pre-Market